MCP-1 and IL-4 encapsulated hydrogel particles with macrophages enrichment and polarization capabilities for systemic lupus erythematosus treatment
Graphical Abstract
Abstract
Macrophages play a pivotal role in systemic lupus erythematosus (SLE) therapy. Efforts have been made to develop multifunctional drug delivery systems capable of directing macrophage polarization. Here, we present a novel hyaluronic acid methacrylate (HAMA) hydrogel microparticle encapsulating multiple cytokines for SLE remission though enhancing macrophage functions. The HAMA microparticles loaded with monocyte chemotactic protein-1 (MCP-1) and interleukin-4 (IL-4) were fabricated by using a microfluidic technology. The released MCP-1 facilitates the aggregation of inflammatory macrophages, after which IL-4 induces the macrophage phenotype shift from inflammatory M1 to immune-protective M2, thus restoring immune balance. We have demonstrated in MRL/lpr mice that the hydrogel microparticles could improve their efficacy of intraperitoneal drug delivery, modulate immune function, and attenuate the disease symptoms. These results suggest that our proposed microparticles delivery platform has potential clinical value for treating autoimmune diseases.
Electronic Supplementary Material
References
Barber, M. R. W.; Johnson, S. R.; Gladman, D. D.; Clarke, A. E.; Bruce, I. N. Evolving concepts in systemic lupus erythematosus damage assessment. Nat. Rev. Rheumatol. 2021, 17, 307–308.
Suárez-Rojas, G.; Crispín, J. C. Dysregulated protein kinase/phosphatase networks in SLE T cells. Clin. Immunol. 2022, 236, 108952.
Tenbrock, K.; Rauen, T. T cell dysregulation in SLE. Clin. Immunol. 2022, 239, 109031.
Koers, J.; Sciarrillo, R.; Derksen, N. I. L.; Vletter, E. M.; Fillié-Grijpma, Y. E.; Raveling-Eelsing, E.; Graça, N. A. G.; Leijser, T.; Pas, H. H.; Laura Van Nijen-Vos, L. et al. Differences in IgG autoantibody Fab glycosylation across autoimmune diseases. J. Allergy Clin. Immunol. 2023, 151, 1646–1654.
Crow, M. K. Pathogenesis of systemic lupus erythematosus: Risks, mechanisms and therapeutic targets. Ann. Rheum. Dis. 2023, 82, 999–1014.
Ruff, W. E.; Dehner, C.; Kim, W. J.; Pagovich, O.; Aguiar, C. L.; Yu, A. T.; Roth, A. S.; Vieira, S. M.; Kriegel, C.; Adeniyi, O. et al. Pathogenic autoreactive T and B cells cross-react with mimotopes expressed by a common human gut commensal to trigger autoimmunity. Cell Host Microbe 2019, 26, 100–113.e8.
Iwata, S.; Hajime Sumikawa, M.; Tanaka, Y. B cell activation via immunometabolism in systemic lupus erythematosus. Front. Immunol. 2023, 14, 1155421.
Zhao, M. M.; Mei, Y.; Zhao, Z. D.; Cao, P. P.; Xin, Y.; Guo, Y. K.; Yang, M.; Wu, H. J. Abnormal lower expression of GPR183 in peripheral blood T and B cell subsets of systemic lupus erythematosus patients. Autoimmunity 2022, 55, 429–442.
Beesley, C. F.; Goldman, N. R.; Taher, T. E.; Denton, C. P.; Abraham, D. J.; Mageed, R. A.; Ong, V. H. Dysregulated B cell function and disease pathogenesis in systemic sclerosis. Front. Immunol. 2023, 13, 999008.
Gu, S. S.; Zhang, J. S.; Han, X. X.; Ding, H. H.; Yao, C.; Ye, Z. Z.; Yin, Z. H.; Hou, G. J.; Jiang, Y.; Qian, J. et al. Involvement of transcriptional factor Pbx1 in peripheral B cell homeostasis to constrain lupus autoimmunity. Arthritis Rheumatol. 2023, 75, 1381–1394.
Lin, Y. H.; Wan, Z. R.; Liu, B.; Yao, J. C.; Li, T. Q.; Yang, F.; Sui, J.; Zhao, Y. S.; Liu, W. L.; Zhou, X. Y. et al. B cell-reactive triad of B cells, follicular helper and regulatory T cells at homeostasis. Cell Res. 2024, 34, 295–308.
Lee, S.; Ko, Y.; Kim, T. J. Homeostasis and regulation of autoreactive B cells. Cell. Mol. Immunol. 2020, 17, 561–569.
Scherer, H. U.; van der Woude, D.; Toes, R. E. M. From risk to chronicity: Evolution of autoreactive B cell and antibody responses in rheumatoid arthritis. Nat. Rev. Rheumatol. 2022, 18, 371–383.
Xia, T. T.; Fu, S. P.; Yang, R. L.; Yang, K.; Lei, W.; Yang, Y.; Zhang, Q.; Zhao, Y. J.; Yu, J.; Yu, L. M. et al. Advances in the study of macrophage polarization in inflammatory immune skin diseases. J. Inflamm. 2023, 20, 33.
Ma, C. Y.; Xia, Y.; Yang, Q. R.; Zhao, Y. R. The contribution of macrophages to systemic lupus erythematosus. Clin. Immunol. 2019, 207, 1–9.
Kwant, L. E.; Vegting, Y.; Tsang-A-Sjoe, M. W. P.; Kwakernaak, A. J.; Vogt, L.; Voskuyl, A. E.; van Vollenhoven, R. F.; de Winther, M. P. J.; Bemelman, F. J.; Anders, H. J. et al. Macrophages in lupus nephritis: Exploring a potential new therapeutic avenue. Autoimmun. Rev. 2022, 21, 103211.
Yoo, E. J.; Oh, K. H.; Piao, H.; Kang, H. J.; Jeong, G. W.; Park, H.; Lee, C. J.; Ryu, H.; Yang, S. H.; Kim, M. G. et al. Macrophage transcription factor TonEBP promotes systemic lupus erythematosus and kidney injury via damage-induced signaling pathways. Kidney Int. 2023, 104, 163–180.
Yan, J. W.; Horng, T. Lipid metabolism in regulation of macrophage functions. Trends Cell Biol. 2020, 30, 979–989.
Chen, T. T.; Cao, Q.; Wang, Y. P.; Harris, D. C. H. M2 macrophages in kidney disease: Biology, therapies, and perspectives. Kidney Int. 2019, 95, 760–773
Chen, S. Z.; Saeed, A. F. U. H.; Liu, Q.; Jiang, Q.; Xu, H. Z.; Xiao, G. G.; Rao, L.; Duo, Y. Macrophages in immunoregulation and therapeutics. Signal Transduct. Target. Ther. 2023, 8, 207.
Wang, J.; Xie, L.; Wang, S. S.; Lin, J. R.; Liang, J.; Xu, J. H. Azithromycin promotes alternatively activated macrophage phenotype in systematic lupus erythematosus via PI3K/Akt signaling pathway. Cell Death Dis. 2018, 9, 1080.
Chato-Astrain, J.; Toledano-Osorio, M.; Alaminos, M.; Toledano, M.; Sanz, M.; Osorio, R. Effect of functionalized titanium particles with dexamethasone-loaded nanospheres on macrophage polarization and activity. Dent. Mater. 2024, 40, 66–79.
Ye, Z. S.; Wang, P. X.; Feng, G. D.; Wang, Q.; Liu, C.; Lu, J.; Chen, J. W.; Liu, P. Q. Cryptotanshinone attenuates LPS-induced acute lung injury by regulating metabolic reprogramming of macrophage. Front. Med. 2022, 9, 1075465.
Zheng, J.; Yang, N.; Wan, Y. Y.; Cheng, W. J.; Zhang, G.; Yu, S.; Yang, B. Y.; Liu, X. Y.; Chen, X. Y.; Ding, X. L. et al. Celastrol-loaded biomimetic nanodrug ameliorates APAP-induced liver injury through modulating macrophage polarization. J. Mol. Med. 2023, 101, 699–716.
Zhu, H. F.; Kong, B.; Nie, M.; Zhao, C.; Liu, R.; Xie, Y.; Zhao, Y. J.; Sun, L. Y. ECM-inspired peptide dendrimer microgels with human MSCs encapsulation for systemic lupus erythematosus treatment. Nano Today 2022, 43, 101454.
Kar, A.; Ahamad, N.; Dewani, M.; Awasthi, L.; Patil, R.; Banerjee, R. Wearable and implantable devices for drug delivery: Applications and challenges. Biomaterials 2022, 283, 121435.
Wang, J. L.; Wang, C.; Wang, Q.; Zhang, Z. H.; Wang, H.; Wang, S. Y.; Chi, Z. C.; Shang, L. R.; Wang, W. Q.; Shu, Y. L. Microfluidic preparation of gelatin methacryloyl microgels as local drug delivery vehicles for hearing loss therapy. ACS Appl. Mater. Interfaces 2022, 14, 46212–46223.
Ding, M.; He, S. J.; Yang, J. MCP-1/CCL2 mediated by autocrine loop of PDGF-BB promotes invasion of lung cancer cell by recruitment of macrophages via CCL2-CCR2 Axis. J. Interferon Cytokine Res. 2019, 39, 224–232.
Puukila, S.; Lawrence, M. D.; De Pasquale, C. G.; Bersten, A. D.; Bihari, S.; McEvoy-May, J.; Nemec-Bakk, A.; Dixon, D. L. Monocyte chemotactic protein (MCP)-1 (CCL2) and its receptor (CCR2) are elevated in chronic heart failure facilitating lung monocyte infiltration and differentiation which may contribute to lung fibrosis. Cytokine 2023, 161, 156060.
Zhu, S. P.; Liu, M.; Bennett, S.; Wang, Z. Y.; Pfleger, K. D. G.; Xu, J. K. The molecular structure and role of CCL2 (MCP-1) and C-C chemokine receptor CCR2 in skeletal biology and diseases. J. Cell. Physiol. 2021, 236, 7211–7222.
Zhang, M. Z.; Wang, X.; Wang, Y. Q.; Niu, A. L.; Wang, S. W.; Zou, C. H.; Harris, R. C. IL-4/IL-13-mediated polarization of renal macrophages/dendritic cells to an M2a phenotype is essential for recovery from acute kidney injury. Kidney Int. 2017, 91, 375–386.
Phu, T. A.; Ng, M.; Vu, N. K.; Bouchareychas, L.; Raffai, R. L. IL-4 polarized human macrophage exosomes control cardiometabolic inflammation and diabetes in obesity. Mol. Ther. 2022, 30, 2274–2297.
Kwon, D.; Cha, B. G.; Cho, Y.; Min, J.; Park, E. B.; Kang, S. J.; Kim, J. Extra-large pore mesoporous silica nanoparticles for directing in vivo M2 macrophage polarization by delivering IL-4. Nano Lett. 2017, 17, 2747–2756.
Risser, G. E.; Machour, M.; Hernaez-Estrada, B.; Li, D.; Levenberg, S.; Spiller, K. L. Effects of interleukin-4 (IL-4)-releasing microparticles and adoptive transfer of macrophages on immunomodulation and angiogenesis. Biomaterials 2023, 296, 122095.
Hachim, D.; Iftikhar, A.; LoPresti, S. T.; Nolfi, A. L.; Ravichandar, S.; Skillen, C. D.; Brown, B. N. Distinct release strategies are required to modulate macrophage phenotype in young versus aged animals. J. Control. Release 2019, 305, 65–74.
Guo, J. H.; Luo, Z. Q.; Wang, F. Y.; Gu, H. C.; Li, M. L. Responsive hydrogel microfibers for biomedical engineering. Smart Med. 2022, 1, e20220003.
Li, W. Z.; Yang, X. Y.; Lai, P. X.; Shang, L. R. Bio‐inspired adhesive hydrogel for biomedicine—principles and design strategies. Smart Med. 2022, 1, e20220024.
Luo, Z. Q.; Wang, Y.; Xu, Y.; Wang, J. L.; Yu, Y. R. Modification and crosslinking strategies for hyaluronic acid‐based hydrogel biomaterials. Smart Med. 2023, 2, e20230029.
Chen, H. X.; Guo, J. H.; Bian, F. K.; Zhao, Y. J. Microfluidic technologies for cell deformability cytometry. Smart Med. 2022, 1, e20220001.
Zhuang, Z. M.; Sun, S. N.; Chen, K. W.; Zhang, Y.; Han, X. M.; Zhang, Y.; Sun, K.; Cheng, F.; Zhang, L. J.; Wang, H. N. Gelatin-based colloidal versus monolithic gels to regulate macrophage-mediated inflammatory response. Tissue Eng. Part C: Methods 2022, 28, 351–362.
Zhao, Z. Y.; Li, G.; Ruan, H. T.; Chen, K. Y.; Cai, Z. W.; Lu, G. H.; Li, R. M.; Deng, L. F.; Cai, M.; Cui, W. G. Capturing magnesium ions via microfluidic hydrogel microspheres for promoting cancellous bone regeneration. ACS Nano 2021, 15, 13041–13054.
Li, Y.; Zhu, H. F.; Liu, R.; Zhao, Y. J.; Sun, L. Y. Hierarchical microcarriers loaded with peptide dendrimer-grafted methotrexate for rheumatoid arthritis treatment. Small Sci. 2024, 4, 2300097.
Lei, L. J.; Lv, Q. Z.; Jin, Y.; An, H.; Shi, Z.; Hu, G.; Yang, Y. Z.; Wang, X. G.; Yang, L. Angiogenic microspheres for the treatment of a thin endometrium. ACS Biomater. Sci. Eng. 2021, 7, 4914–4920.
Chang, L. K.; Xu, Y. L.; Wu, Z. Y.; Shao, Y. C.; Yu, D.; Yang, W. Y.; Ye, L. Y.; Wang, X. Y.; Li, B. B.; Yin, Y. X. Hyaluronic acid methacrylate/laponite hydrogel loaded with BMP4 and maintaining its bioactivity for scar-free wound healing. Regen. Biomater. 2023, 10, rbad023.
Nie, M.; Chen, G. P.; Zhao, C.; Gan, J. J.; Alip, M.; Zhao, Y. J.; Sun, L. Y. Bio-inspired adhesive porous particles with human MSCs encapsulation for systemic lupus erythematosus treatment. Bioact. Mater. 2021, 6, 84–90.
Fu, J.; Sun, Z. G.; Wang, X.; Zhang, T.; Yuan, W. J.; Salem, F.; Yu, S. M. W.; Zhang, W. J.; Lee, K.; He, J. C. The single-cell landscape of kidney immune cells reveals transcriptional heterogeneity in early diabetic kidney disease. Kidney Int. 2022, 102, 1291–1304.
Horuluoglu, B.; Bayik, D.; Kayraklioglu, N.; Goguet, E.; Kaplan, M. J.; Klinman, D. M. PAM3 supports the generation of M2-like macrophages from lupus patient monocytes and improves disease outcome in murine lupus. J. Autoimmun. 2019, 99, 24–32
Saito, K.; Mori, S.; Kodama, T. McH- lpr/ lpr-RA1 mice: A novel spontaneous mouse model of autoimmune sialadenitis. Immunol. Lett. 2021, 237, 3–10.
Weinstein, A. Cell-bound complement activation products are superior to serum complement C3 and C4 levels to detect complement activation in systemic lupus erythematosus: Comment on the article by Aringer et al. Arthritis Rheumatol. 2020, 72, 860.
Pan, H. D.; Wang, J. R.; Liang, Y.; Wang, C. J.; Tian, R. M.; Ye, H.; Zhang, X.; Wu, Y. H.; Shao, M.; Zhang, R. J. et al. Serum IgG glycan hallmarks of systemic lupus erythematosus. Engineering 2023, 26, 89–98.
京公网安备11010802044758号